The OpenFold Consortium released a preview of OpenFold3, an Apache 2.0-licensed foundation model that predicts 3D protein structures and co-folded complexes with small-molecule ligands, nucleic acids and other proteins, positioning it for industry use at scale. Simultaneously, Apheris, a Berlin-based provider of enterprise-grade AI applications for drug discovery, launched ApherisFold to run, benchmark, and fine-tune…
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape
GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…